In summary, our findings demonstrated that breast cancer cells exhibit aberrant glycolytic metabolism mediated through a Zeb1-dependent mechanism that confers aggressive and immunosuppressive properties to tumors. The gene discussed is ZEB1; the disease is breast carcinoma.